Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Conditions:   Oral Squamous Cell Carcinoma;   Oral Mucositis Interventions:   Drug: Alfacalcidol Oral Solution;   Drug: Placebo Sponsor:   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Condition:   Breast Cancer Intervention:   Drug: metronomic oral vinorelbine plus anlotinib Sponsor:   Yan Xue Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Conditions:   Oral Squamous Cell Carcinoma;   Oral Mucositis Interventions:   Drug: Alfacalcidol Oral Solution;   Drug: Placebo Sponsor:   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Condition:   Breast Cancer Intervention:   Drug: metronomic oral vinorelbine plus anlotinib Sponsor:   Yan Xue Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Conditions:   Oral Squamous Cell Carcinoma;   Oral Mucositis Interventions:   Drug: Alfacalcidol Oral Solution;   Drug: Placebo Sponsor:   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Condition:   Breast Cancer Intervention:   Drug: metronomic oral vinorelbine plus anlotinib Sponsor:   Yan Xue Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Conditions:   Oral Squamous Cell Carcinoma;   Oral Mucositis Interventions:   Drug: Alfacalcidol Oral Solution;   Drug: Placebo Sponsor:   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Condition:   Breast Cancer Intervention:   Drug: metronomic oral vinorelbine plus anlotinib Sponsor:   Yan Xue Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Conditions:   Oral Squamous Cell Carcinoma;   Oral Mucositis Interventions:   Drug: Alfacalcidol Oral Solution;   Drug: Placebo Sponsor:   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Condition:   Breast Cancer Intervention:   Drug: metronomic oral vinorelbine plus anlotinib Sponsor:   Yan Xue Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Conditions:   Oral Squamous Cell Carcinoma;   Oral Mucositis Interventions:   Drug: Alfacalcidol Oral Solution;   Drug: Placebo Sponsor:   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Condition:   Breast Cancer Intervention:   Drug: metronomic oral vinorelbine plus anlotinib Sponsor:   Yan Xue Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Conditions:   Oral Squamous Cell Carcinoma;   Oral Mucositis Interventions:   Drug: Alfacalcidol Oral Solution;   Drug: Placebo Sponsor:   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Condition:   Breast Cancer Intervention:   Drug: metronomic oral vinorelbine plus anlotinib Sponsor:   Yan Xue Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Conditions:   Oral Squamous Cell Carcinoma;   Oral Mucositis Interventions:   Drug: Alfacalcidol Oral Solution;   Drug: Placebo Sponsor:   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials